Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsThe last two decades have seen significant growth in cancer research with considerable advancements made in the cell and gene therapy (CAGT) field across the world. In Asia Pacific (APAC), the rapid expansion of innovative cancer treatments is expected to continue given the current clinical trial trends in the region, particularly pertaining to the potential and capability of the availability of centers, patient recruitment and regulatory landscape in key markets.
Featuring discussion and knowledge from an advisory board involving key opinion leaders (KOLs) across Australia, China, Japan, New Zealand, Singapore, South Korea and Taiwan, this white paper explores the growing success and potential of the CAGT market landscape in Asia Pacific. Download the white paper to find out how CAGT is transforming cancer treatment across the APAC region.
To learn more about IQVIA APAC’s CAGT solutions, please click here.